Catherine M. Szyman - Jul 7, 2023 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP, Critical Care
Signature
Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
Jul 7, 2023
Transactions value $
-$291,646
Form type
4
Date filed
7/10/2023, 05:09 PM
Previous filing
Jun 13, 2023
Next filing
Aug 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Tax liability -$22.8K -252 -0.72% $90.46 34.8K Jul 7, 2023 Direct
transaction EW Common Stock Options Exercise $184K +5K +14.36% $36.75 39.8K Jul 10, 2023 Direct F1
transaction EW Common Stock Sale -$453K -5K -12.56% $90.52 34.8K Jul 10, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -5K -7.46% $0.00 62K Jul 10, 2023 Common Stock 5K $36.75 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2023.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.